# Simvastatin in the Prevention of Recurrent Pancreatitis

> **NCT04021498** · PHASE3 · TERMINATED · sponsor: **Enrique de-Madaria** · enrollment: 83 (actual)

## Conditions studied

- Pancreatitis Relapsing

## Interventions

- **DRUG:** Simvastatin 40mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04021498
- **Lead sponsor:** Enrique de-Madaria
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-29
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 83 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04021498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04021498, "Simvastatin in the Prevention of Recurrent Pancreatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04021498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*